Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanzi Huangshi No. 2
- Development stage
- Unknown
- Lead developer
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Sanzi Huangshi No. 2 is a Traditional Chinese Medicine (TCM) formulation developed by the Shanghai Municipal Hospital of Traditional Chinese Medicine and Shanghai University of Traditional Chinese Medicine. It is primarily investigated for the treatment of low-risk myelodysplastic syndrome (MDS). The formulation is typically administered as pills and is often evaluated in combination with thalidomide to assess its efficacy in improving hematological parameters and managing disease progression. As a TCM product, its therapeutic effects are thought to involve multi-target modulation of the hematopoietic microenvironment and immune regulation, aimed at improving blood cell counts and reducing the risk of transformation in MDS patients.
- Brand names
- Sanzi Huangshi No. 2
- Other names
- Sanzi Huangshi No. 2 pillsSanzi Huangshi Er Hao
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))BAX (Apoptosis regulator BAX)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Sanzi Huangshi No. 2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanzi Huangshi No. 2.